Quick Answer
Bioventus Inc. reported Net Income of $22.73 million for fiscal year 2025.
Bioventus Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | $22.73M | +162.9% |
| 2024 | -$36.12M | +76.9% |
| 2023 | -$156.23M | +1.6% |
| 2022 | -$158.70M | -919.1% |
| 2021 | $19.38M | +18.1% |
| 2020 | $16.41M | +139.5% |
| 2019 | $6.85M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $3.15M | +161.1% | -57.7% |
| June 30, 2025 | $7.46M | +129.0% | +382.9% |
| March 31, 2025 | -$2.64M | +46.1% | +48.9% |
| September 30, 2024 | -$5.17M | +29.3% | +79.9% |
| June 30, 2024 | -$25.68M | -597.7% | -425.2% |
| March 31, 2024 | -$4.89M | +96.5% | +33.0% |
| September 30, 2023 | -$7.30M | +93.3% | -98.4% |
| June 30, 2023 | -$3.68M | +49.2% | +97.4% |
- Bioventus Inc. showed an increase of +162.9% in Net Income compared to the prior fiscal year.
- Over the 2019–2025 period, Bioventus Inc.’s net income has grown by 231.8% (from $6.85 million to $22.73 million).
- The most recent figure is from Bioventus Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 5, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: